Seliger B, Pfizenmaier K, Schäfer R
Ludwig Institute for Cancer Research, Stockholm Branch, Sweden.
J Virol. 1991 Nov;65(11):6307-11. doi: 10.1128/JVI.65.11.6307-6311.1991.
Persistent revertants have been generated from NIH 3T3 cells transformed by an activated human Ha-ras gene after short-term gamma interferon treatment in the presence of the cardiac aminoglycoside ouabain. Normal fibroblastlike morphology and anchorage dependence are restored in revertants. Tumorigenicity in nude mice is abolished. The revertants continue to express high steady-state levels of the ras oncogene. Partial retransformation of reverted cells is induced after 5-azacytidine treatment or after infection with retrovirus vectors carrying the v-abl, v-fes, v-myc, or v-src oncogene. The revertants resist the transforming activities of the v-Ha-ras and v-mos oncogenes.
在心脏氨基糖苷哇巴因存在的情况下,经短期γ干扰素处理后,由活化的人Ha-ras基因转化的NIH 3T3细胞产生了持久性回复突变体。回复突变体恢复了正常的成纤维细胞样形态和贴壁依赖性。裸鼠中的致瘤性被消除。回复突变体继续高水平稳定表达ras癌基因。用5-氮杂胞苷处理或用携带v-abl、v-fes、v-myc或v-src癌基因的逆转录病毒载体感染后,诱导回复细胞发生部分再转化。回复突变体对v-Ha-ras和v-mos癌基因的转化活性具有抗性。